share_log

Cantor Fitzgerald Maintains Overweight on Cresco Labs, Lowers Price Target to $15

Benzinga Real-time News ·  Aug 18, 2022 17:30

Cantor Fitzgerald analyst Pablo Zuanic maintains Cresco Labs (OTC:CRLBF) with a Overweight and lowers the price target from $19 to $15.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment